Hemostatic complications associated with ventricular assist devices

Talal Hilal, James Mudd, Thomas G. DeLoughery

    Research output: Contribution to journalReview articlepeer-review

    11 Scopus citations


    Hemostatic complications are common in patients with ventricular assist devices. The pathophysiologic mechanisms that lead to dysregulated hemostasis involve complex interactions between device surface, sheer stress, and blood flow. These factors lead to various manifestations that require a thorough understanding of the interplay among platelets, coagulation factors, and red cells. In this article, we review the pathophysiology of hematologic complications (bleeding, acquired von Willebrand disease, heparin-induced thrombocytopenia, hemolysis, stroke and pump thrombosis), the clinical manifestations, and the management of each. We summarize the evidence available for management of these entities and provide a pragmatic clinical review.

    Original languageEnglish (US)
    Pages (from-to)589-598
    Number of pages10
    JournalResearch and Practice in Thrombosis and Haemostasis
    Issue number4
    StatePublished - Oct 1 2019


    • heart-assist devices
    • hemostasis
    • heparin-induced thrombocytopenia
    • thrombosis
    • ventricular assist devices
    • von Willebrand diseases

    ASJC Scopus subject areas

    • Hematology


    Dive into the research topics of 'Hemostatic complications associated with ventricular assist devices'. Together they form a unique fingerprint.

    Cite this